Applicant, as named in the Orange Book

Inforlife

Next listed expiry: Midazolam In 0.9% Sodium Chloride on 20 Jun 2038. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Midazolam In 0.9% Sodium Chloride NDA 211844 · 2 strengths midazolam	midazolam	20 Jun 2038 patent	patent
Norepinephrine Bitartrate In 0.9% Sodium Chloride NDA 215700 · 4 strengths norepinephrine bitartrate	norepinephrine bitartrate	26 Apr 2039 patent	patent

Norepinephrine Bitartrate In 0.9% Sodium Chloride · Generic approved · ANDA 220483, SagentApproved 26 Mar 2026Detected 25 Oct 2026

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Zoledronic Acid NDA 203231 zoledronic acid	zoledronic acid	open now no listed protection	no listed protection